Daxor files 510(k) for injection syringe:
This article was originally published in Clinica
Daxor has filed a 510(k) submission with the US FDA for a quantitative syringe kit for use with its BVA-100 blood volume analyser. The syringe is designed to deliver more than 99.9% of its content in diagnostic studies in which a precise and complete injection is required. Daxor, based in New York, has been awaiting clearance for its BVA-100 system since November last year.